Summary

27
Fecal IgA production depends on colonization by a gut microbiota. However, the bacterial 28 strains that drive gut IgA production remain largely unknown. By accessing the IgA-inducing 29 capacity of a diverse set of human gut microbial strains, we identified Bacteroides ovatus as the 30 species that best induced gut IgA production. However, this induction varied bimodally across 31 different B. ovatus strains. The high IgA-inducing B. ovatus strains preferentially elicited more 32
IgA production in the large intestine largely through the T-cell-dependent B cell-activation 33 pathway. Remarkably, a low-IgA phenotype in mice could be robustly and consistently 34 converted into a high-IgA phenotype by transplanting a multiplex cocktail of high IgA-inducing B. Here we demonstrate that, upon transfer into GF mice, human isolates of the Bacteroides 82 ovatus species, one of the most common human gut commensals, are uniquely capable of 83 inducing high mucosal IgA production compared with other common gut commensal species. 84
This IgA-inducing capacity, however, was restricted to specific strains of B. ovatus that 85 preferentially led to IgA production in the large intestine through both T-cell-dependent (TD) and 86
T-cell-independent (TI) B cell-activation pathways. While no individual bacterial strain functioned 87
as an effective enhancer of gut IgA production, we found that cocktails of these high IgA-88 inducing (IgA high ) strains could serve as effective immunomodulators, that elicited higher fecal 89
IgA levels upon administration to animals harboring a pre-existing microbiota with low IgA-90 inducing potential (IgA low ). Our work demonstrates the importance of strain-level variation in gut 91 microbiota composition on mucosal immune responses. It also supports the potential utility of 92 cultured multi-bacterial effector strain cocktails as a strategy to overcome phenotype transfer 93 resistance in microbiota-based immunomodulation (Petrof and Khoruts, 2014 monocolonized GF C57BL/6 mice with one of eight different human gut commensal bacteria 99 (Table S1) To address if the order of bacterial colonization could influence fecal IgA secretion, GF 112 mice were sequentially colonized every three weeks with individual species or small cocktails of 113 the same eight bacterial species. We first assayed fecal IgA level in mice sequentially colonized 114 with low IgA inducers (i.e. E. coli) to high IgA inducers (i.e. B. ovatus) ( Figure S1D ). Fecal IgA 115 increased gradually with the colonization of additional bacterial species. However, the more 116 striking (>2-fold) increase in IgA occurred after colonization with B. ovatus ( Figure 1B) . 117
Metagenomic sequencing of fecal microbiota in these mice revealed gut colonization by each 118 bacterial species, albeit with different proportions ( Figure 1C ). We then reversed the order of 119 colonization from high IgA inducers (i.e. B. ovatus) to low IgA inducers (i.e. E. coli) (Figure  120 S1D). Once again, B. ovatus elicited the largest increase of fecal IgA production, while the other 121 species led to smaller increases ( Figure 1D ). Remarkably, the relative abundance of each 122 organism at the end of the colonization was very similar, regardless of the order of colonization 123
( Figures 1C and 1E ). These results demonstrate that B. ovatus is a uniquely potent gut IgA 124 inducer and that the species composition of the gut microbiota impacts IgA production more 125 than the order of bacterial colonization. 126
To test the role of bacterial viability in the induction of gut IgA by B. ovatus (Hapfelmeier et (Table S2)  143 showed a strain-specific gut IgA response ( Figure 1F ; p < 0.0001). In contrast to the large 144 variability of fecal IgA levels, serum IgA levels were comparable across mice monocolonized 145 with different B. ovatus strains ( Figure S2A) . Similarly, the colonization density was also 146 comparable across mice harboring different B. ovatus strains ( Figure S2B ). This observation 147
suggests that the global density of each individual strain was not implicated in the genesis of 148 strain-specific differences of gut IgA responses. Of note, the distribution pattern of IgA induction 149 across multiple B. ovatus strains was bimodal ( Figure S2C; Figure 1G and Table  152 S3), which suggests that their distinct IgA-inducing function is shared amongst the species 153 rather than representing an evolutionarily distinct group within the species. 154
To rule out a bias in our preliminary screen for IgA low strains within the Bacteroides genus, 155
we assayed whether additional strains could induce high fecal IgA ( Figure 1A ). We found no 156 strain-specific differences in fecal IgA induction when GF mice were monocolonized with three 157 distinct strains of B. caccae, B. thetaiotaomicron and B. vulgatus ( Figure S2D Figures S4A and S4B) . 217
Given the preferential expansion of IgA-secreting B cells in the colon of monocolonized 218 mice harboring B. ovatus strain E, we then explored whether luminal IgA levels would vary 219 between small and large intestinal regions. In the small intestine, we found that mice 220 monocolonized with B. ovatus strain E or Q had comparable luminal IgA levels ( Figure 2D ). In 221 contrast, mice monocolonized with strain E had significantly more luminal IgA from cecum to 222 distal colon than those colonized with strain Q ( Figure 2D IgA high strain having a distinct relative abundance ( Figure 4E ). Finally, we replicated these 280 results in mice pre-colonized with another IgA low B. ovatus strain R (Figures S8C and S8D) . 281
To validate these results in the setting of more complex gut microbiotas, we performed 282 similar experiments using either gnotobiotic mice pre-colonized by a synthetic cocktail of diverse 283 bacterial species that included B. ovatus IgA low strain Q (Table S5) Since B. ovatus strain C had a high relative abundance after DMT with B. ovatus 4M 293 across multiple recipient microbiotas, we examined whether this strain itself could convert low-294
IgA producing mice to high-IgA producing mice. In receipt mice pre-colonized with either B. 295 ovatus strain Q or microbiota arrayed culture collection (i.e. HuLib1175B), transplantation of B. 296 ovatus strain C alone did not significantly increase fecal IgA on its own (Fig. 4d,f and 297 Supplementary Fig. 9a,b) . 298
To further validate the IgA-inducing properties of our multiplex IgA high B. ovatus cocktails, 299
we tested these cocktails in two additional gnotobiotic mouse models pre-colonized by human 300 microbiota arrayed culture collections with low-IgA potential (Table S6) IgA production ( Figure S10G-S10I Immunofluorescence staining was performed as described previously (Moon et al., 2015) . 
